We are live on
!
Find out more
Agios Pharmaceuticals
AGIO
AGIO
160 hedge funds and large institutions have $1.95B invested in Agios Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 47 increasing their positions, 61 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
5.71% more ownership
Funds ownership: 103.31% → 109.02% (+5.7%)
2% less funds holding
Funds holding: 164 → 160 (-4)
13% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 32
23% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 61
31% less capital invested
Capital invested by funds: $2.81B → $1.95B (-$865M)
51% less call options, than puts
Call options by funds: $6.91M | Put options by funds: $14M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
160
Holders Change
-4
Holders Change %
-2.44%
% of All Funds
2.46%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
28
Increased
47
Reduced
61
Closed
32
Calls
$6.91M
Puts
$14M
Net Calls
-$7.06M
Net Calls Change
-$3.42M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$56.9M |
| 2 |
JP Morgan Chase
New York
|
-$46M |
| 3 |
ClearBridge Investments
New York
|
-$42.7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$15.2M |
| 5 |
BlackRock
New York
|
-$14M |
